With the FDA approval of the first specific drug for Metabolic Associated Steatohepatitis (MASH) in March this year, Madrigal’s Rezdiffra is a pioneer in a market set for rapid change.

The blockbuster Novo Nordisk obesity drug Wegovy has met the main goals of a pivotal test in metabolic dysfunction steatohepatitis, or MASH, results the drugmaker says support expanding the ...

Novo Nordisk will seek regulatory approval of semaglutide, the key ingredient in its popular weight loss medicine, in a common liver disease following positive results in a Phase 3 trial, the company ...

Taking to the platform ‘X’, Arzoo Kazmi wrote #Photo of the Day 😍😍😍 Mashallah 😍 😍. The 23rd SCO CHG kicked off on Wednesday in Islamabad, with top-notch security measures in place.